Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Kahl

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|November 10, 2024
Reply to: "Dysglycemia and liver lipid content influence the link between insulin resistance and liver mitochondrial function in obesity"Sabine Kahl, Michael Roden
Nature Reviews. Endocrinology|July 5, 2018
Amino acids - lifesaver or killer in patients with diabetes?Sabine Kahl, Michael Roden
Deutsches Arzteblatt International|December 23, 2021
Collider Bias in Observational StudiesThaddäus Tönnies, Sabine Kahl, Oliver Kuss
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity?Benjamin Schröder, Sabine Kahl, Michael Roden
Seminars in Liver Disease|July 21, 2021
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic SteatohepatitisSabine Kahl, Jennifer Pützer, Michael Roden
Metabolism: Clinical and Experimental|May 23, 2024
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?Maximilian Huttasch, Michael Roden, Sabine Kahl
Metabolism: Clinical and Experimental|June 23, 2020
Metabolic liver disease in diabetes - From mechanisms to clinical trialsBedair Dewidar, Sabine Kahl, Kalliopi Pafili, et al.
Deutsche Medizinische Wochenschrift (1946)|November 14, 2013
[Rare cause for severe hypertriglyceridemia - case 9/2013]Sabine Kahl, Michael Roden, Klaus Mörike, et al.
Physiological Reviews|January 3, 2014
L-type CaV1.2 calcium channels: from in vitro findings to in vivo functionFranz Hofmann, Veit Flockerzi, Sabine Kahl, et al.
Diabetologia|July 23, 2014
Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trialSabine Kahl, Bettina Nowotny, Simon Piepel, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|November 10, 2024
Reply to: "Dysglycemia and liver lipid content influence the link between insulin resistance and liver mitochondrial function in obesity"Sabine Kahl, Michael Roden
Nature Reviews. Endocrinology|July 5, 2018
Amino acids - lifesaver or killer in patients with diabetes?Sabine Kahl, Michael Roden
Deutsches Arzteblatt International|December 23, 2021
Collider Bias in Observational StudiesThaddäus Tönnies, Sabine Kahl, Oliver Kuss
Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
Non-alcoholic fatty liver disease in type 2 diabetes - A specific entity?Benjamin Schröder, Sabine Kahl, Michael Roden
Seminars in Liver Disease|July 21, 2021
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic SteatohepatitisSabine Kahl, Jennifer Pützer, Michael Roden
Metabolism: Clinical and Experimental|May 23, 2024
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?Maximilian Huttasch, Michael Roden, Sabine Kahl
Metabolism: Clinical and Experimental|June 23, 2020
Metabolic liver disease in diabetes - From mechanisms to clinical trialsBedair Dewidar, Sabine Kahl, Kalliopi Pafili, et al.
Deutsche Medizinische Wochenschrift (1946)|November 14, 2013
[Rare cause for severe hypertriglyceridemia - case 9/2013]Sabine Kahl, Michael Roden, Klaus Mörike, et al.
Physiological Reviews|January 3, 2014
L-type CaV1.2 calcium channels: from in vitro findings to in vivo functionFranz Hofmann, Veit Flockerzi, Sabine Kahl, et al.
Diabetologia|July 23, 2014
Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trialSabine Kahl, Bettina Nowotny, Simon Piepel, et al.
Pageof 6